作者: Jenny V Garmendia , Dolores Moreno , Alexis H Garcia , Juan B De Sanctis
DOI: 10.2174/1872214807666140107151023
关键词: Obesity 、 Pediatrics 、 Medicine 、 Metabolic syndrome 、 Endocrine control 、 Asthma 、 Pharmacological treatment 、 Comorbidity 、 Physical therapy 、 Insulin resistance 、 Dyslipidemia
摘要: Metabolic syndrome (MetS) is a that involves at least three disorders dyslipidemia, insulin resistance, obesity and/or hypertension. MetS has been associated with several chronic diseases in the adulthood; however, recent years, was redefined children. Girls early menarche and asthma, children asthma reach adulthood appear to have higher risk develop severe or difficult control probability suffer cardiovascular diseases. It proposed patients endocrinological should be considered different entity which pharmacologic treatment adjusted according individual. Recent patents on field addressed new issues how endocrine managed along therapeutics. In near future, approaches decrease high morbidity mortality these types of patients.